Skip to content
Search

Latest Stories

Boots transfers £4.8 Billion Pension Plan to Legal & General

Boots transfers £4.8 Billion Pension Plan to Legal & General

Boots also brings in an additional payment of around £500m to the scheme

Walgreens Boots Alliance (WBA), which owns the retail pharmacy chain Boots in the UK, has signed a buy-in deal with financial services company Legal & General, transferring its £4.8 billion ($6 billion) pension plan to the latter.


In a release issued on Friday, the company said that the deal is the “largest single transaction of its kind,” in the UK and insures all 53,000 members in the Boots Pension Scheme.

The company said it was the best options to “safeguard members’ benefit against market uncertainty, improved life expectancies and other risks”.

Boots is also bringing in an additional payment of around £500m to the scheme, in addition to the sum (£170m) it has already committed.

Boots Pension Scheme trustee chair Alan Baker is optimistic that this agreement with Legal & General will give “added protection to our members’ long-term benefits by removing market uncertainty and other financial exposures.”

"The scheme will not be reliant on Boots to pay benefits to members and pensions will be protected for decades to come," he added.

L&G will assume the responsibility for issuing individual annuity policies to scheme members and paying benefits directly to them.

However, the business said will take up to two years to complete the process of moving the members, after which it will bear most of the scheme’s economic risk.

Boots UK managing director Seb James commented that they “have fully secured the benefits of all members with a highly respected insurer” and this will provide “greater certainty to both the scheme members and to Boots and is an excellent outcome for both parties."

Describing the deal as their “largest ever single transaction”, Legal & General CEO Kail said it was a proof to their “long-standing relationship with the client.

Earlier, the WBA had agreed to guarantee the scheme but the agreement has been terminated and replaced with a smaller, temporary guarantee.

More For You

Omega Pharmacy in Derbyshire Finds New Owner in Just 18 Days

Omega Pharmacy

Christie & Co

Omega Pharmacy in Derbyshire sold in just 18 days

Omega Pharmacy in Derbyshire has found a new owner in less than three weeks after being put on the market.

The pharmacy was previously owned by husband-and-wife duo Manny and Poonam Rai, who decided to sell it after a short period of ownership to focus on their other pharmacy in Coventry, according to Christie & Co.

Keep ReadingShow less
DHSC announces second list of March 2025 price concessions

A price concession only applies for the month it is granted.

Getty Images

March price concessions list released; prescription charge remains unchanged

The Department of Health and Social Care (DHSC) has released a second list of price concessions for March 2025, following ongoing discussions with Community Pharmacy England (CPE) regarding medicine pricing concerns raised by pharmacy owners.

A price concession is introduced when pharmacy contractors are unable to source a drug at or below the reimbursement price set out in the Drug Tariff.

Keep ReadingShow less
AstraZeneca partners with CEPI to develop multi-specific influenza antibody

AstraZeneca-CEPI collaboration aims to increase global access to antibody-based interventions

Getty Images

AstraZeneca secures £33M CEPI funding to develop multi-specific influenza antibody

AstraZeneca has joined forces with the Coalition for Epidemic Preparedness Innovations (CEPI) to advance an innovative antibody technology that could help tackle future infectious disease outbreaks and pandemics swiftly and more affordably.

CEPI will provide up to US$43.5 million (£33.6 million) in funding to support the biopharmaceutical company in evaluating a type of antibody, known as a VHH (Variable Heavy domain of a Heavy chain -only antibody), through preclinical proof-of-concept studies and Phase 1 clinical trials.

Keep ReadingShow less
Community Pharmacy Patient Safety Group announces new vice-chair

Martin Sadr-Kazemi 's appointment follows the passing of Dr. José Moss in January 2025.

Martin Sadr-Kazemi appointed vice-chair of Community Pharmacy Patient Safety Group

The Community Pharmacy Patient Safety Group (CPPSG) has announced the appointment of Martin Sadr-Kazemi as its new vice-chair.

Martin, currently the medication safety officer and deputy superintendent pharmacist at Rowlands Pharmacy, has been an integral member of the CPPSG since its formation a decade ago, actively contributing to various initiatives.

Keep ReadingShow less
"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar

Pic credit: London Ambulance Service

"My work benefits all across London," says ambulance pharmacy technician

Mahrukh Jaffar will create history when she becomes the first apprentice to become a qualified pharmacy technician through the London Ambulance Service.

Jaffar is just days away from completing her registration with the General Pharmaceutical Council.

Keep ReadingShow less